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Abstract
Background: There are few studies in Brazil that address baseline prevalence of MRSA colonization and associated
risk factors at hospital admission, or the incidence of nosocomial colonization. We report a prospective study in a
tertiary-care, university-affiliated hospital to implement a new MRSA control policy at the institution.
Methods: A cohort of randomly selected patients admitted to emergency and clinical wards at our hospital was
followed until discharge. Nasal swabs were taken for identification of MRSA-colonized patients and detection of
SCCmecA in positive cultures, at admission and weekly thereafter. Multivariate analysis using a log-binomial analysis
was used to identify risk factors for colonization.
Results: After screening 297 adult patients and 176 pediatric patients, the prevalence of MRSA at admission was
6.1% (95%CI, 3.6% to 9.4%), in the adult population and 2.3% (95%CI, 0.6% to 5.7%), for children. From multivariate
analysis, the risk factors associated with colonization in adults were: age above 60 years (P = 0.019) and
hospitalization in the previous year (P = 0.022). Incidence analysis was performed in 276 MRSA-negative patients
(175 adults and 101 children). Acquisition rate was 5.5/1,000 patient-days for adults (95%CI, 3.4 to 8.5/1,000
patients-days), and 1.1/1,000 patient-days for children (95%CI, 0.1 to 4.0/1,000 patients-days).
Conclusions: The identification of MRSA carriers is a step towards establishing a control policy for MRSA, and helps
to identify measures needed to reduce colonization pressure and to decrease the high acquisition rate in
hospitalized patients.
Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
cross-transmitted in hospital settings, and has a high
impact not only on patient morbidity and mortality but
also on hospitalization costs. Worldwide, it has been
endemic in many healthcare facilities since the 1990 s
[1]. MRSA remains a major pathogen in nosocomial
infections in developing countries [2] and in Latin
America, according to SENTRY [3].
The fact that a patient can harbor MRSA at hospital
admission has consequences not just for the choice of
patient treatment: it also impacts on the effectiveness of
infection control in the hospital. MRSA reservoir at hos-
pital can make other measures of infection control not
as effective, thereby causing pathogen transmission to
continue [4]. Guidelines aimed at controlling the spread
of MRSA therefore propose to systematically search for
colonized patients, and then to isolate and decolonize
them [5]. This policy has not been tested rigorously in
methodologically-sound randomized trials, and most of
the evidence comes from observational and quasi-
experimental studies [6]. There is also concern about
the cost of such measures and the lack of available
rooms for isolation [7].
Recently-published studies have arrived at different
results regarding identification and isolation of MRSA
colonized patients. These differences may be attributable
to many factors, ranging from differences between the
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multifaceted nature of infection control practices. In one
study, universal MRSA surveillance reduced the infec-
tion risk during hospitalization and 30 days after dis-
charge [8], while another study evaluated MRSA
screening at admission in surgical patients in an ende-
mic setting of MRSA, and found no decrease in surgical
site infections and nosocomial acquisition of MRSA [9].
Yet another study in an intensive care unit (ICU) com-
pared two interventions to reduce transmission of
MRSA, after identification of colonized patients by the
pathogen: cohort-isolation o single room isolation, and
found no difference in cross-transmission between the
two periods [10].
In Brazil, MRSA is endemic in hospitals [3], but few
studies have looked at MRSA colonization. One study
that screened patients in an emergency department
found 0.7% of patients colonized with MRSA at admis-
sion [11]. In ICUs, one study reported 13% of patients
colonized at admission [12], and another [13] found
46% patients colonized. In this ICU, 51% of non-colo-
nized patients acquired MRSA colonization [13].
We agree that the identification of baseline rates and
the associated risk factors of colonization are necessary
to estimate the burden of colonization and the demands
for isolation facilities [14], and to help adopt a cost-
effective strategy of patient screening which would take
into consideration the population prevalence of MRSA
and the structure of the hospital [15]. Thus, use of own
data, obtained from a study that uses local resources
can help to propose a policy that fits the institutional
needs and lead to satisfactory outcomes regarding
MRSA control.
The present study aims to estimate the prevalence of
MRSA colonization and infection in clinical adult and
pediatric patients at the time of admission to hospital;
the incidence of colonization and infection during hos-
pitalization; and the potential risk factors for both, in a
hospital in southern Brazil, in order to obtain informa-
tion to support infection control planning for MRSA
policy in the institution.
Methods
Study Setting and Population
A prospective cohort study was made of patients
admitted to the Hospital de Clínicas in Porto Alegre, an
urban tertiary-care, public university-affiliated teaching
hospital, with 749 beds, with three adult ICUs, one
pediatric and one neonatal ICU. The hospital provides
care in medical and surgical specialties. The infection
control team performs hospital-wide, hospital-acquired
infection (HAI) surveillance in all wards and in the hos-
pital ICUs. There is a protocol for vancomycin-resistant
enterococci (VRE) screening in patients transferred from
other healthcare facilities, but there is no screening for
MRSA colonization. Patients with clinical cultures who
grew resistant micro-organisms were subject to isolation
precautions and were placed in isolation rooms, depend-
ing on the availability of the latter.
We randomly selected adult (patients above 14 years
old) and pediatric (14 years old or less) patients, in their
first 72 hours of admission to the hospital. For logistic
reasons, patients were selected from Mondays to Thurs-
days, since information collected for the hospital’sc o r -
porate database indicates that there was no difference in
clinical characteristics between patients admitted to the
hospital on weekdays, and those admitted at weekends.
On each of these days, one of the researchers (HBS)
checked the admission of clinical patients who had
arrived on the previous day. Surgical, gynecology/obste-
tric, neonatology or psychiatric patients were not
included. For patients admitted to the emergency room
(ER), the researcher asked the assistant physician to
identify which of those were expected to stay for longer
than 48 h in the hospital, so as to include them in the
list. A number was assigned to each patient in two sepa-
rated lists, one for the adult patients and another one
for pediatric patients. Three adults and two children
were randomly selected from respective list each day.
Informed consent was obtained from patients or their
caregivers. If a patient could not sign the informed con-
sent and we were unable to contact a relative, we substi-
tuted that person for another randomly-selected patient
from the list, whenever possible. Patients who had been
selected in a previous admission could have been
included, but were excluded from the statistical analysis.
Data collection
After selection, and after informed consent had been
given, trained researchers interviewed patients or those
responsible for them. A standard form was used to
record data. The researchers obtained clinical informa-
tion from assistant physicians and medical residents,
and from electronic medical records about diagnosis to
calculate a Charlson Comorbidity Index. Information
regarding previous use of drugs and previous hospitali-
zations were obtained from patients or the persons
responsible for them. We chose not to obtain this infor-
mation from electronic medical records because not all
patients had previous hospitalization at the hospital, use
of hospital records could therefore have led to a mea-
surement bias.
A sample from the anterior nare was collected to
identify MRSA colonization, with a swab moistened in
sterile saline solution. Patients were followed until hos-
pital discharge, with swabs collected weekly until eight
samples had been collected and, whenever possible,
another was collected at the moment of discharge. Swab
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The Charlson Comorbidity Score (CCS) was used for
risk adjustment [16].
To obtain information about MRSA infection at
admission or during hospitalization, we also searched
for MRSA in clinical cultures collected as part of the
routine hospital care provided to the selected patients.
Microbiologic Methods
The swabs were transported in a Stuart’s medium to the
microbiology laboratory. All samples were processed
using a mannitol salt agar medium (Himedia) with 6 ug/
mL of oxacillin. The plates of mannitol salt agar were
i n c u b a t e da t3 5 ° Cf o r2 4t o4 8h o u r s .C o l o n i e sw i t h
indication of mannitol fermentation were submitted to
the coagulase test to confirm S. aureus identification.
These colonies were also tested with a 30 μg cefoxitin
disc (Oxoid) in a Mueller Hinton plate for oxacillin
resistance [17].
For PCR detection of SCCmecA, the technique
described by Vannuffel et al. [18] was used.
Definitions
A patient was deemed to be colonized when a screening
specimen grew MRSA; and was deemed infected when a
clinical specimen was positive for MRSA. Admission
cultures were those taken up to 72 hours after hospital
admission. In Brazil, the Brazilian National Health Regu-
latory Agency (ANVISA) uses this cutoff as a criterion
for nosocomial infection [19].
Statistical Analysis
Sample size was calculated with EpiInfo 6.0, considering
a prevalence of 5% of colonized patients at admission
[14,20,21] and confidence level of 95%. The study sam-
ple was stratified into two groups, adult and pediatric,
and we calculated a sample size of 300 adults and 200
pediatric patients. When data for the entire sample were
shown, the results of the strata were weighted according
to the percentage of clinical adult and pediatric patients
in hospital.
Analyses were performed using SPSS 15.0 for Windows
(SPSS Inc.). We used chi-square tests, with Fisher’s Exact
Test if indicated, for categorical variables, and Student’s
t-test or the Mann-Whitney U test for continuous vari-
ables in univariate analyses. To determine potential risk
factors for colonization at admission or acquisition of
colonization, we performed, respectively, log-binomial
regression [22] and survival analysis with Cox regression.
The multivariate analysis included variables with P < 0.20
in the univariate analysis, and the final model included
those with P<0 , 0 5 . The study was submitted and was
approved by the hospital’s Ethics Committee (project
number 05-341), and was approved.
Results
From May, 2006 to March, 2007, 1,561 patients met the
inclusion criteria, and 580 were selected (Figure 1). The
final sample consisted of 473 patients (297 adults, 176
children). For incidence analysis, we followed 276
patients who had at least a second swab during hospita-
lization, and who had a negative culture at admission.
There were 5,414 days of hospitalization. The first
swabs were collected within 24 hours of admission for
377 patients, up 48 hours after admission for 95 patients
and up 72 hours of admission for one patient.
Sixteen adult patients had been colonized with MRSA
at admission (5.4%; 95%CI, 3.1% to 8.6%), and two were
infected as shown by blood and skin ulcer secretion.
Three (1.7%; 95%CI 0.4% to 4.9%) pediatric patients
were colonized and one was infected (sputum) at admis-
sion. Weighted prevalence of MRSA at admission for
the whole sample was 5.3% (95%CI, 4.5 to 6.2%). None
of the patients with clinical cultures positive for MRSA
at admission had positive nasal swabs, and none of the
colonized patients developed a clinical infection with
MRSA while hospitalized, although one of them received
empirical vancomycin.
Table 1 shows the characteristics of the patients at
admission, according to their MRSA status (positive or
negative). For the children, none of the characteristics
was associated with colonization or infection with
MRSA. Hospitalization in the last year (PR = 5.3, 95%CI
1.2 to 22.5, P = 0.011) and age above 60 years (PR = 2.8,
95%CI 1.1 to 7.2, P = 0.046) were factors associated with
colonization in adults in the univariate analysis.
Multivariate analysis with log-binomial regression for
the adults included the variables age above 60 years,
previous admission, previous use of antibiotics and
transfer from another hospital or from long term care
facility (Table 2); both age above 60 years and previous
hospital admission were associated with an increased
risk of MRSA colonization at admission (PR = 3.0, 95%
CI 1.2 to 7.7 and PR = 5.6, 95%CI 1.3 to 23.9,
respectively).
Weighted incidence of MRSA was 9.6% (95%CI 8.1 to
11.1) for the patients followed during hospitalization.
Twenty adults acquired colonization during hospitaliza-
tion (incidence rate, 5.5/1,000 patient-days, 95%CI, 3.4
to 8.5), and two children became colonized (incidence
rate, 1.1/1,000 patient-days (95%CI, 0.1 to 4.0).
The incidence of colonization increased with increase
length of stay, and was statistically significant (P <
0.001). It reached 2.9% in week two, 4.9% in week three,
2.4% in week four, 8.9% in week five, zero in week six,
9.1% in week seven and zero in week eight. For those
patients with negative cultures at admission and have
acquired colonization, the median number of days from
admission until positive cultures were obtained from
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patients with positive screening cultures had spent a
mean of 4.05 days (median, 3) in the emergency, while
patients with negative cultures, 2.72 days (median, 2), (P
= 0.147 for the comparison, using a Mann-Whitney
test).
The crude survival analysis with adult patients could
not identify any risk factors associated with acquisition
of colonization or infection; a multivariate analysis
included Charlson Comorbidity Score (HR 1.1, 95%CI
0.7 to 1.6), presence of HIV infection (HR 1.2, 95%CI
0.1 to 10.1) and admission by ER (HR 3.0, 95%CI 0.7 to
13.3). None of these factors was associated with acquisi-
tion of MRSA (Table 3).
W ei d e n t i f i e dt h eg e n o t y p eo f3 6o ft h e4 1p a t i e n t s
with positive swabs. For the positive patients at admis-
sion, the SCCmecA genes present were type I in five
patients and type III in eight. For the patients that
1,561 patients met inclusion criteria 
1,047 adult patients  514 pediatric patients 
357 randomly selected 
303 evaluated  200 evaluated 
223 randomly selected 
297 included in the analysis 
of prevalence at admission 
279 not colonized at 
admission 
6 excluded: 
2 without admission swab 
4 included in previous admission 
54 refused to participate or 
did not give consent 
18 patients with positive cultures: 
16 colonized 
2 infected 
175 with at least a second 
swab during hospitalization 
20 colonized with MRSA 
during hospitalization 
176 included in the analysis 
of prevalence at admission 
172 not colonized at 
admission 
2 colonized with MRSA 
during hospitalization 
104 discharged without a second 
swab 
24 excluded: 
11 without admission swab 
13 included in previous admission 
23 refused to participate or 
did not give consent 
4 patients with positive cultures: 
3 colonized 
1 infected 
101 with at least a second 
swab during hospitalization 
71 discharged without a second 
swab 
Figure 1 Patients’ flow chart in the study.
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seven patients, SCCmecA type III in twelve and
SCCmecA type IV in two.
Discussion
Our study found a prevalence of MRSA colonization at
admission that is higher than that previous reported in
patients admitted to emergency service in Brazil [11],
and may reflect the chronic nature of patients in a ter-
tiary care hospital. Sixty-four percent of our sample had
had at least one hospitalization in the previous year, and
this was associated with colonization at admission. The
results of SCCmecA, which mainly disclosed those types
associated with hospital strains, also confirmed this pro-
file. Moreover, the two strains with SCCmecA type IV
acquired after admission are in agreement with a study
that reported hospital dissemination of CA-MRSA in
hospitals in Detroit [23].
However, even thought 70% of all pediatric patients
had been admitted to a hospital in the last year, 19% of
them with a neoplastic disease, the prevalence of coloni-
zation proved to be low in children. In Brazil, another
study also reported low prevalence of MRSA in hospita-
lized children younger than five years (1%), and all
strains harbored SCCmecA type III [24]. The number of
positive children was too small for performing a multi-
variate analysis.
The two risk factors found for colonization at admis-
sion in our adult patients have been reported elsewhere
in the literature [25]. However, there are also other risk
factors associated with MRSA colonization that have
Table 1 Characteristics of admitted patients included in the study
Variable Pediatric patients Adult patients
Negative Positive Negative Positive
(N = 172) (N = 4) (N = 279) (N = 18)
Male sex (%) 101 (58.7) 2 (50.0) 157(56.3) 10 (55.6)
Mean age, years (SD) 4.1 (4.2) 7.8 (5.1) 54.1 (18.3) 59.8 (22.7)
Transfer (%)# 18 (10.5) 0 (0.0) 12 (4.3) 2 (11.1)
Admission by ER (%) 105 (61.0) 2 (50.0) 223 (79.9) 15 (83.3)
Median LOS, days (IQR) 8.0 (12.0) 11.0 (32.0) 11.0 (16.0) 14.0 (12.0)
Hospital admission last year (%)
Median N admissions(IQR)*
116 (67.4)
1.0 (3.0)
4 (100.0)
2.0 (5.0)
163 (58.4)
1 (2.0)
16 (88.9)
4(5.0)
Ambulatory care (%)§ 27 (15.7) 1 (25.0) 50 (17.9) 4 (22.2)
Previous MRSA (%) 30 (17.4) 2 (50.0) 22 (7.9) 1 (5.6)
Antimicrobials 2 wks before (%) 66 (38.4) 2 (50.0) 75 (26.9) 9 (50.0)
Corticosteroids 2 wks before (%) 30 (17.4) 1(25.0) 23 (8.2) 3 (16.7)
Immunosupressors 2 wks before (%) 4 (2.3) 0 (0.0) 15 (5.4) 0 (0.0)
Skin lesions (%) 38 (22.1) 1 (25.0) 55 (19.7) 3 (16.7)
HIV infection (%) 5 (2.9) 0 (0) 31 (11.1) 1 (5.6)
Diabetes mellitus (%) 2 (1.2) 1 (25.0) 53 (19.0) 4 (22.2)
Any neoplasia (%) 33 (19.2) 1 (25.0) 4 (30.1) 5 (27.8)
Pulmonary disease (%) 37 (21.6) 2 (50.0) 31 (11.1) 1 (5.6)
ER: Emergency Room, LOS: length of stay, IQR: interquartile range, wks: weeks, MRSA: Methicillin-resistant Staphylococcus aureus HIV: human immunodeficiency
virus
# Transfer from another hospital or long term care facility
* in patients with at least one admission in the last year
§ Ambulatory care due chronic condition: dialysis and/or chemotherapy and/or radiotherapy
¶ Cystic Fibrosis, Asthma or Chronic Obstructive Pulmonary Disease
Table 2 Multivariate analysis with risk factors for
prevalence of MRSA colonization at admission in adults -
log-binomial regression (N = 297)
Variable PR (95%CI)
Age above 60 years 3.0 (1.2-7.7)
Transfer from another hospital or long term care facility 2.9 (0.8-11.0)
Use of antimicrobials 2 wks before 2.3 (0.9-5.5)
Hospital admission last year 5.6 (1.3-23.9)
MRSA: Methicillin-resistant Staphylococcus aureus
Table 3 Multivariate analysis with risk factors for
acquisition of MRSA colonization during hospitalization
in adults - Cox regression (N = 175)
Variable HR (95%CI)
Admission by ER 2.9 (0.6-12.7)
HIV infection 1.1 (0.1-9.5)
Ward transfers 1.3 (0.7-2.4)
CCI 1.1 (0.7-1.6)
MRSA: Methicillin-resistant Staphylococcus aureus: ER emergency room; HIV:
human immunodeficiency virus; CCI: Charlson Comorbidity Index
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infection or with treatment for hemodyalisis. This may
be due to the small number of those patients in the
population under study, and the consequent lack of
power to identify such associations, which is a limitation
of our study. Another limitation may be related to the
lack of association between previous drug use (i.e. anti-
biotic, corticosteroids or other immunosupressors) and
MRSA harboring. This may reflect an information bias
b e c a u s em o s tp a t i e n t si nt h es t u d yw e r en o ta b l et o
report the name or type of the drugs that they had been
using in the recent past.
The high incidence of colonization between hospita-
lized patients is a matter of concern. Two other studies
in Brazil have also shown a high incidence rate of colo-
nization [12,13], although they were in ICU settings,
where patients are more exposed to invasive procedures
(intravenous catheters, urinary catheters and mechanical
ventilation) with higher rates of colonization. We could
not identify any particular risk factor for this acquisition,
but we followed a heterogeneous sample of patients, and
the CCS may not be the most appropriate tool for use
in studies with resistant pathogens [26]. The proportion
of patients in study which became colonized each week
increased and this is in accordance with the fact that
patients who remain longer in hospital are exposed to
more interventions (eg, by invasive procedures, contacts
with healthcare workers, antimicrobials use) which may
raise the risk of acquisition of a pathogen.
The number of colonized patients may have been
underestimated since screening used only one site, and
this is a limitation of the study. However, we wished to
estimate how much work was involved in screening
patients in a pragmatic study, in which the primary
objective was to characterize the incidence of coloniza-
tion by MRSA in an environment with high endemic
levels. The lack of resources for a comprehensive strat-
egy of universal MRSA screening demands a targeted
approach that could result in a reduction of MRSA
transmission, using the hospital capacity. Also, we did
not adjusted for current use of prophylactic antibiotics
used by oncologic patients (mainly, trimethropim-sulfa-
methozaxole), which may have affected colonization.
Indeed, some patients received vancomycin because of
suspected MRSA infection; this also could have biased
the results of the nasal cultures, but the use of antimi-
crobial was not associated with colonization.
Almost 40% of the original sample that tested negative
at admission was discharged at the weekend, without a
second swab. This fact could have overestimated the
incidence of colonization, because patients that had a
shorter stay were less ill than the other patients, and
have had a lower risk of becoming colonized.
Finally, if we consider the risk factors for adults at the
time of admission, our findings suggest that the hospital
should be able to screen 78% of those patients being
admitted (all adult patients with admission in previous
year and/or aged 60 years or more). This appears to be
a high percentage if we consider isolating the patients
while waiting the results of the cultures, as it would put
them in isolation for 24% of their days in hospital. But if
we look at the incidence rate found (5.5/1,000 patient-
days), this measure could help lessen colonization pres-
sure in the hospital. Another important point is that
these newly-colonized patients would probably be read-
mitted, so maintaining the chain of MRSA transmission.
We also consider that this high prevalence of MRSA
colonization at admission is a matter for concern, since
the hospital emergency department is overcrowded and
in this population the median time spent in the emer-
gency department was two days before admission to an
acute-care ward. Another Brazilian study has found that
patients colonized or infected with multidrug-resistant
bacterial organisms had a higher length of stay than
controls in the ER, and a higher associated mortality
[27]. The presence of colonized patients in a chronically
overcrowded and understaffed ER may represent
another substantial obstacle to implementing hospital
infection control measures [28], especially where
resources are limited, and thus requiring specifically
customized strategies.
Conclusions
Although MRSA infection is a very frequent pathogen in
Brazilian hospitals, [2,3], there are few data regarding
patient colonization [11-13]. Even though the universal
screening is not a resolved issue, knowledge of the mag-
nitude of colonization is invaluable for planning to con-
trol the pathogen. In a heterogeneous sample of clinical
patients admitted to a Brazilian hospital, a high preva-
lence of MRSA colonization was found, and the results
of the study provide the basis for better-targeted MRSA
control policies aimed at specific groups of patients. The
study also gives an estimate of the resources needed for
a particular hospital to implement such interventions,
especially where funds are limited.
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